{"organizations": [], "uuid": "1b5f8c3c5bc680c86f0cfd784842391ae9403887", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180516.html", "section_title": "Archive News &amp; Video for Wednesday, 16 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-corrected-veloxis-pharmaceuticals/brief-corrected-idUSL5N1SN7LQ", "country": "US", "domain_rank": 408, "title": "BRIEF-CORRECTED-(OFFICIAL)-Veloxis Pharmaceuticals maintains 2018 Outlook Of Revenues (May 14)", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.01, "site_type": "news", "published": "2018-05-17T06:26:00.000+03:00", "replies_count": 0, "uuid": "1b5f8c3c5bc680c86f0cfd784842391ae9403887"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-corrected-veloxis-pharmaceuticals/brief-corrected-idUSL5N1SN7LQ", "ord_in_thread": 0, "title": "BRIEF-CORRECTED-(OFFICIAL)-Veloxis Pharmaceuticals maintains 2018 Outlook Of Revenues (May 14)", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "veloxis pharmaceuticals", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 16 (Reuters) - Veloxis Pharmaceuticals A/S:\n* VELOXIS PHARMACEUTICALS - MAINTAINS ITS 2018 OUTLOOK OF OPERATING LOSS BEFORE ACCOUNTING FOR STOCK COMPENSATION IN RANGE OF USD 6 MILLIONâ€“12 MILLION\n* REG-VELOXIS PHARMACEUTICALS ANNOUNCES FINANCIAL RESULTS FOR THE FIRST THREE MONTHS OF 2018\n* QTRLY PRODUCT REVENUE FOR Q1 2018 WAS TUSD 7,265 AN INCREASE OF 142% COMPARED TO SAME PERIOD LAST YEAR\n* VELOXIS MAINTAINS ITS 2018 OUTLOOK OF REVENUES TO BE IN RANGE OF USD 32 MILLION- USD 40 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-17T06:26:00.000+03:00", "crawled": "2018-05-17T14:44:42.034+03:00", "highlightTitle": ""}